Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 7 May 1993:
Vol. 260. no. 5109, pp. 819 - 822
DOI: 10.1126/science.8484123
Prev | Table of Contents | Next

Articles

Science, Vol 260, Issue 5109, 819-822
Copyright © 1993 by American Association for the Advancement of Science

articles

Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages

WR Jacobs Jr, RG Barletta, R Udani, J Chan, G Kalkut, G Sosne, T Kieser, GJ Sarkis, GF Hatfull, and BR Bloom

Howard Hughes Medical Institute, Albert Einstein College of Medicine, Bronx, NY 10461.

Effective chemotherapy of tuberculosis requires rapid assessment of drug sensitivity because of the emergence of multidrug-resistant Mycobacterium tuberculosis. Drug susceptibility was assessed by a simple method based on the efficient production of photons by viable mycobacteria infected with specific reporter phages expressing the firefly luciferase gene. Light production was dependent on phage infection, expression of the luciferase gene, and the level of cellular adenosine triphosphate. Signals could be detected within minutes after infection of virulent M. tuberculosis with reporter phages. Culture of conventional strains with antituberculosis drugs, including isoniazid or rifampicin, resulted in extinction of light production. In contrast, light signals after luciferase reporter phage infection of drug-resistant strains continued to be produced. Luciferase reporter phages may help to reduce the time required for establishing antibiotic sensitivity of M. tuberculosis strains from weeks to days and to accelerate screening for new antituberculosis drugs.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
GenoType MTBDRplus Assay for Molecular Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis Strains and Clinical Samples.
A. Lacoma, N. Garcia-Sierra, C. Prat, J. Ruiz-Manzano, L. Haba, S. Roses, J. Maldonado, and J. Dominguez (2008)
J. Clin. Microbiol. 46, 3660-3667
   Abstract »    Full Text »    PDF »
Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis.
R. Mole, A. Trollip, C. Abrahams, M. Bosman, and H. Albert (2007)
J. Med. Microbiol. 56, 1334-1339
   Abstract »    Full Text »    PDF »
Promoter and Transcription Analysis of Penicillin-Binding Protein Genes in Streptococcus gordonii.
M. Haenni, P. Moreillon, and V. Lazarevic (2007)
Antimicrob. Agents Chemother. 51, 2774-2783
   Abstract »    Full Text »    PDF »
Detection of Live and Antibiotic-Killed Bacteria by Quantitative Real-Time PCR of Specific Fragments of rRNA..
S. Aellen, Y.-A. Que, B. Guignard, M. Haenni, and P. Moreillon (2006)
Antimicrob. Agents Chemother. 50, 1913-1920
   Abstract »    Full Text »    PDF »
Host range of 14 mycobacteriophages in Mycobacterium ulcerans and seven other mycobacteria including Mycobacterium tuberculosis - application for identification and susceptibility testing.
J. Rybniker, S. Kramme, and P. L. Small (2006)
J. Med. Microbiol. 55, 37-42
   Abstract »    Full Text »    PDF »
Use of Leishmania donovani Field Isolates Expressing the Luciferase Reporter Gene in In Vitro Drug Screening.
Ashutosh, S. Gupta, Ramesh, S. Sundar, and N. Goyal (2005)
Antimicrob. Agents Chemother. 49, 3776-3783
   Abstract »    Full Text »    PDF »
Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine Tuberculosis.
E. L. Nuermberger, T. Yoshimatsu, S. Tyagi, K. Williams, I. Rosenthal, R. J. O'Brien, A. A. Vernon, R. E. Chaisson, W. R. Bishai, and J. H. Grosset (2004)
Am. J. Respir. Crit. Care Med. 170, 1131-1134
   Abstract »    Full Text »    PDF »
Rapid Detection of Escherichia coli O157:H7 by Using Green Fluorescent Protein-Labeled PP01 Bacteriophage.
M. Oda, M. Morita, H. Unno, and Y. Tanji (2004)
Appl. Envir. Microbiol. 70, 527-534
   Abstract »    Full Text »    PDF »
Photographic and Luminometric Detection of Luciferase Reporter Phages for Drug Susceptibility Testing of Clinical Mycobacterium tuberculosis Isolates.
M. H. Hazbon, N. Guarin, B. E. Ferro, A. L. Rodriguez, L. A. Labrada, R. Tovar, P. F. Riska, and W. R. Jacobs Jr. (2003)
J. Clin. Microbiol. 41, 4865-4869
   Abstract »    Full Text »    PDF »
Usefulness of a New Mycobacteriophage-Based Technique for Rapid Diagnosis of Pulmonary Tuberculosis.
F. Alcaide, N. Gali, J. Dominguez, P. Berlanga, S. Blanco, P. Orus, and R. Martin (2003)
J. Clin. Microbiol. 41, 2867-2871
   Abstract »    Full Text »    PDF »
Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages.
N. Banaiee, M. Bobadilla-del-Valle, P. F. Riska, S. Bardarov Jr, P. M. Small, A. Ponce-de-Leon, W. R. Jacobs Jr, G. F. Hatfull, and J. Sifuentes-Osornio (2003)
J. Med. Microbiol. 52, 557-561
   Abstract »    Full Text »    PDF »
Utility of an In-House Mycobacteriophage-Based Assay for Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis Clinical Isolates.
N. Gali, J. Dominguez, S. Blanco, C. Prat, M. D. Quesada, L. Matas, and V. Ausina (2003)
J. Clin. Microbiol. 41, 2647-2649
   Abstract »    Full Text »    PDF »
Use of a Phage-Based Assay for Phenotypic Detection of Mycobacteria Directly from Sputum.
D. J. Park, F. A. Drobniewski, A. Meyer, and S. M. Wilson (2003)
J. Clin. Microbiol. 41, 680-688
   Abstract »    Full Text »    PDF »
Changing Approaches to the Diagnosis of Tuberculosis.
N. W. SCHLUGER (2001)
Am. J. Respir. Crit. Care Med. 164, 2020-2024
   Full Text »    PDF »
Luciferase Reporter Mycobacteriophages for Detection, Identification, and Antibiotic Susceptibility Testing of Mycobacterium tuberculosis in Mexico.
N. Banaiee, M. Bobadilla-del-Valle, S. Bardarov Jr., P. F. Riska, P. M. Small, A. Ponce-de-Leon, W. R. Jacobs Jr., G. F. Hatfull, and J. Sifuentes-Osornio (2001)
J. Clin. Microbiol. 39, 3883-3888
   Abstract »    Full Text »    PDF »
DNA Transformation of Leishmania infantum Axenic Amastigotes and Their Use in Drug Screening.
D. Sereno, G. Roy, J. L. Lemesre, B. Papadopoulou, and M. Ouellette (2001)
Antimicrob. Agents Chemother. 45, 1168-1173
   Abstract »    Full Text »
Validation of a Noninvasive, Real-Time Imaging Technology Using Bioluminescent Escherichia coli in the Neutropenic Mouse Thigh Model of Infection.
H. L. Rocchetta, C. J. Boylan, J. W. Foley, P. W. Iversen, D. L. LeTourneau, C. L. McMillian, P. R. Contag, D. E. Jenkins, and T. R. Parr Jr. (2001)
Antimicrob. Agents Chemother. 45, 129-137
   Abstract »    Full Text »
Noninvasive measurement of gene expression in skeletal muscle.
G. Walter, E. R. Barton, and H. L. Sweeney (2000)
PNAS 97, 5151-5155
   Abstract »    Full Text »    PDF »
Evaluation of a Bacteriophage-Based Assay (Phage Amplified Biologically Assay) as a Rapid Screen for Resistance to Isoniazid, Ethambutol, Streptomycin, Pyrazinamide, and Ciprofloxacin among Clinical Isolates of Mycobacterium tuberculosis.
I. J. Eltringham, S. M. Wilson, and F. A. Drobniewski (1999)
J. Clin. Microbiol. 37, 3528-3532
   Abstract »    Full Text »
Assessment of Immunity to Mycobacterial Infection with Luciferase Reporter Constructs.
V. A. Snewin, M.-P. Gares, P. O Gaora, Z. Hasan, I. N. Brown, and D. B. Young (1999)
Infect. Immun. 67, 4586-4593
   Abstract »    Full Text »    PDF »
Effect of Stimulation of Human Macrophages on Intracellular Survival of Mycobacterium bovis Bacillus Calmette-Guerin . Evaluation with a Mycobacterial Reporter Strain.
M. BONAY, F. BOUCHONNET, V. PELICIC, B. LAGIER, M. GRANDSAIGNE, D. LECOSSIER, A. GRODET, M. VOKURKA, B. GICQUEL, and A. J. HANCE (1999)
Am. J. Respir. Crit. Care Med. 159, 1629-1637
   Abstract »    Full Text »    PDF »
Rapid Film-Based Determination of Antibiotic Susceptibilities of Mycobacterium tuberculosis Strains by Using a Luciferase Reporter Phage and the Bronx Box.
P. F. Riska, Y. Su, S. Bardarov, L. Freundlich, G. Sarkis, G. Hatfull, C. Carrière, V. Kumar, J. Chan, and W. R. Jacobs Jr. (1999)
J. Clin. Microbiol. 37, 1144-1149
   Abstract »    Full Text »
Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography.
S. S. Gambhir, J. R. Barrio, M. E. Phelps, M. Iyer, M. Namavari, N. Satyamurthy, L. Wu, L. A. Green, E. Bauer, D. C. MacLaren, et al. (1999)
PNAS 96, 2333-2338
   Abstract »    Full Text »    PDF »
Exposure to Antibiotics Induces Expression of the Mycobacterium tuberculosis sigF Gene: Implications for Chemotherapy against Mycobacterial Persistors.
T. M. Michele, C. Ko, and W. R. Bishai (1999)
Antimicrob. Agents Chemother. 43, 218-225
   Abstract »    Full Text »
Relationship between genetic alteration of the rpsL gene and streptomycin susceptibility of Mycobacterium tuberculosis in Japan.
M. Fukuda, H. Koga, H. Ohno, B. Yang, Y. Hirakata, S. Maesaki, K. Tomono, T. Tashiro, and S. Kohno (1999)
J. Antimicrob. Chemother. 43, 281-284
   Abstract »    Full Text »    PDF »
Development of a Firefly Luciferase-Based Assay for Determining Antimicrobial Susceptibility of Mycobacterium avium subsp. paratuberculosis.
S. L. Williams, N. B. Harris, and R. G. Barletta (1999)
J. Clin. Microbiol. 37, 304-309
   Abstract »    Full Text »
Generation of Bioluminescent Streptococcus mutans and Its Usage in Rapid Analysis of the Efficacy of Antimicrobial Compounds.
V. Loimaranta, J. Tenovuo, L. Koivisto, and M. Karp (1998)
Antimicrob. Agents Chemother. 42, 1906-1910
   Abstract »    Full Text »
Flow Cytometric Testing of Susceptibilities of Mycobacterium tuberculosis Isolates to Ethambutol, Isoniazid, and Rifampin in 24 Hours.
S. M. Kirk, R. F. Schell, A. V. Moore, S. M. Callister, and G. H. Mazurek (1998)
J. Clin. Microbiol. 36, 1568-1573
   Abstract »    Full Text »
Use of 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyl Tetrazolium Bromide for Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis.
R. N. Mshana, G. Tadesse, G. Abate, and H. Miörner (1998)
J. Clin. Microbiol. 36, 1214-1219
   Abstract »    Full Text »
Identification of a New DNA Region Specific for Members of Mycobacterium tuberculosis Complex.
J. Magdalena, A. Vachée, P. Supply, and C. Locht (1998)
J. Clin. Microbiol. 36, 937-943
   Abstract »    Full Text »
Development of a suicide gene as a novel approach to killing Mycobacterium tuberculosis.
W. Rom, T. Yie, and K. Tchou-Wong (1997)
Am. J. Respir. Crit. Care Med. 156, 1993-1998
   Abstract »    Full Text »
Conditionally replicating mycobacteriophages: A system for transposon delivery to Mycobacterium tuberculosis.
S. Bardarov, J. Kriakov, C. Carriere, S. Yu, C. Vaamonde, R. A. McAdam, B. R. Bloom, G. F. Hatfull, and W. R. Jacobs Jr. (1997)
PNAS 94, 10961-10966
   Abstract »    Full Text »    PDF »
Research Issues Involving HIV-Associated Tuberculosis in Resource-Poor Countries.
K. M. De Cock, N. J. Binkin, P. L. F. Zuber, J. W. Tappero, and K. G. Castro (1996)
JAMA 276, 1502-1507
   Abstract »    PDF »
Tuberculosis Research: Balancing the Portfolio.
P. M. Small (1996)
JAMA 276, 1512-1513
   Abstract »    PDF »
Diagnosis and Detection of Drug-Resistant Strains of M. tuberculosis.
(1995)
AIDS Clinical Care 1995, 1
   Full Text »
New test catches drug-resistant TB in the spotlight.
M Barinaga (1993)
Science 260, 750
   PDF »
In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene.
A. Auricchio, R. Zhou, J. M. Wilson, and J. D. Glickson (2001)
PNAS 98, 5205-5210
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)